Trials / Conditions / Malignant Rhabdoid Tumor

Malignant Rhabdoid Tumor

10 registered clinical trials studyying Malignant Rhabdoid Tumor — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-speci NCT07148050	Seattle Children's Hospital	Phase 1
Recruiting	Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296	Baylor College of Medicine	Phase 1
Recruiting	Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatri NCT04715191	Baylor College of Medicine	Phase 1
Active Not Recruiting	Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid NCT04377932	Baylor College of Medicine	Phase 1
Active Not Recruiting	Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid NCT05103631	Baylor College of Medicine	Phase 1
Active Not Recruiting	Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers NCT04416568	Dana-Farber Cancer Institute	Phase 2
Terminated	A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT NCT04897880	Australian & New Zealand Children's Haematology/Oncology Group	Phase 2
Completed	Molecular-Guided Therapy for Childhood Cancer NCT02162732	Giselle Sholler	N/A
Active Not Recruiting	Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors NCT02114229	St. Jude Children's Research Hospital	Phase 2
No Longer Available	Tazemetostat Expanded Access Program for Adults With Solid Tumors NCT03874455	Epizyme, Inc.	—